Bioactive compounds:safety and efficacy

Biesalski, Hans-Konrad, Dragsted, Lars Ove, Elmadfa, Ibrahim, Grossklaus, Rolf, Müller, Michael ORCID: https://orcid.org/0000-0002-5930-9905, Schrenk, Dieter, Walter, Paul and Weber, Peter (2009) Bioactive compounds:safety and efficacy. Nutrition, 25 (11-12). pp. 1206-1211. ISSN 1873-1244

Full text not available from this repository. (Request a copy)

Abstract

The efficacy and safety of bioactive compounds depend on a few known and unknown parameters. What is a physiologic dose and how can that dose be defined in cases of bioactive compounds with a poor knowledge of supply and distribution? What safety sets are needed? How can individual aspects such as polymorphisms or differences in absorption be considered? A group of experts tried to answer these and related questions during the 23rd Hohenheim Consensus Meeting at the University of Hohenheim in Stuttgart.

Item Type:	Article
Uncontrolled Keywords:	biological markers,biological products,dietary supplements,drug dosage calculations,humans,intestinal absorption,polymorphism, genetic
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology
Depositing User:	Pure Connector
Date Deposited:	21 Feb 2014 11:54
Last Modified:	24 Oct 2022 06:07
URI:	https://ueaeprints.uea.ac.uk/id/eprint/47699
DOI:	10.1016/j.nut.2009.06.014

Actions (login required)

View Item